Neurotrophic Factors: Building a Stronger, Resilient Brain
Neurotrophic factors are molecules that play a crucial role in the growth, differentiation, and survival of neurons in the central and peripheral nervous systems. They are essential for the development and maintenance of healthy neural circuitry and can be divided into two main classes: neurotrophins and glial cell line-derived neurotrophic factor (GDNF) family ligands. Neurotrophins are secreted proteins that include nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophin-3 (NT-3). GDNF family ligands include GDNF itself, neurturin, persephin, and artemin. Neurotrophic factors influence neuronal development, plasticity, and survival, and are involved in a variety of neurological disorders, such as Alzheimer’s disease, Parkinson’s disease, and autism.
Neurotrophic factors are required for normal development of the peripheral and central nervous systems. They are involved in the growth, differentiation, and maintenance of neurons, and are essential for the formation of functional neural circuits. They can promote the migration and differentiation of neuronal precursors, and stimulate the survival of immature neurons. Neurotrophic factors can also modulate the excitability of neurons and regulate synaptic plasticity.
Neurotrophic factors have been implicated in a variety of neurological disorders, including Alzheimer’s disease, Parkinson’s disease, and autism. In Alzheimer’s disease, decreased levels of nerve growth factor (NGF) have been observed in the brain, and there is evidence that BDNF and NT-3 may be involved in the progression of the disease. In Parkinson’s disease, there is evidence that GDNF and its related ligands may be involved in the progression of the disease. In autism, BDNF has been shown to play a role in the development of the disease.
In conclusion, neurotrophic factors are essential for the development and maintenance of healthy neural circuitry. They are involved in a variety of neurological disorders, including Alzheimer’s disease, Parkinson’s disease, and autism. Further research is needed to better understand the role of neurotrophic factors in neurological disorders and to develop new treatments.
References
Butovsky, O., Koronyo-Hamaoui, M., Kunis, G., Ophir, E., Landa, G., Cohen, H., & Schwartz, M. (2014). Microglia-mediated neurotrophic factor secretion and synaptic plasticity. Trends in Neurosciences, 37(12), 696-705. https://doi.org/10.1016/j.tins.2014.09.002
Kishimoto, Y., Yamazaki, M., & Nabeshima, T. (2011). Role of neurotrophic factors in Alzheimer’s disease pathogenesis. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 10(5), 681-690. https://doi.org/10.2174/187152711798214104
Miller, S. J., & Boulanger, L. M. (2015). Neurotrophic factors in normal brain development and in neurodevelopmental disorders. Molecular Psychiatry, 20(1), 66-75. https://doi.org/10.1038/mp.2014.86
Mufson, E. J., & Kordower, J. H. (2015). Neurotrophic factor therapies for Parkinson’s disease. Nature Reviews Neuroscience, 16(10), 595-608. https://doi.org/10.1038/nrn3998
